The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary safety, pharmacokinetics, and efficacy results from an open-label, multicenter, Phase I/II study of avapritinib in Chinese patients with unresectable or metastatic gastrointestinal stromal tumors (GIST).
 
Jian Li
No Relationships to Disclose
 
Jifang Gong
No Relationships to Disclose
 
Xicheng Wang
No Relationships to Disclose
 
Jie Li
No Relationships to Disclose
 
Yan Li
No Relationships to Disclose
 
Changsong QI
No Relationships to Disclose
 
Lin Shen
No Relationships to Disclose
 
Wenxiao Ren
Employment - CStone Pharmaceuticals
Stock and Other Ownership Interests - CStone Pharmaceuticals
 
Wanqi Zhao
Employment - CStone Pharmaceuticals; Lilly
 
Yedong Wang
Employment - CStone Pharmaceuticals
 
Jin Hu
Employment - CStone Pharmaceuticals
 
Chunli Ren
Employment - CStone Pharmaceuticals
Stock and Other Ownership Interests - CStone Pharmaceuticals
 
Wenjie Song
Employment - CStone Pharmaceuticals
 
Jianxin Yang
Employment - CStone Pharmaceuticals
Leadership - CStone Pharmaceuticals
Stock and Other Ownership Interests - CStone Pharmaceuticals